SCHEMBL7957534

SCHEMBL7957534

Fc1ccc(N2CCN(CCCc3cnn4c3CCCC4)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 8/20 0.58
DRD4 P21917 4/20 0.58
HTR1A P08908 10/20 0.50
HTR2A P28223 8/20 0.50
DRD2 P14416 8/20 0.50
SIGMAR1 Q99720 5/20 0.50
TMEM97 Q5BJF2 4/20 0.50
HTR2C P28335 4/20 0.50
HRH1 P35367 4/20 0.50
DRD1 P21728 4/20 0.48
DRD5 P21918 3/20 0.48
SLC6A4 P31645 3/20 0.43
PARP1 P09874 1/20 0.42
MPO P05164 1/20 0.42
CHRM1 P11229 1/20 0.42
HTR2B P41595 1/20 0.42
HTR6 P50406 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7959479 0.89 DRD3 (0.75) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7961393 0.89 DRD4 (0.58) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7959339 0.88 DRD4 (0.58) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7960985 0.77 HTR1A (0.54) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7949594 0.77 HTR1A (0.54) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7961390 0.76 HTR1A (0.51) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7959986 0.74 HTR1A (0.51) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7957460 0.73 HTR1A (0.48) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL8011318 0.72 DRD2 (0.69) DRD3DRD4HTR1AHTR2ADRD2
SCHEMBL7949256 0.72 THRB (0.47) DRD3DRD4HTR1AHTR2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP claimed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed